Breaking News

Citigroup to Take Pretax Settlement Charge of About $3.8B in Second Quarter
Tweet TWEET

Zacks Sell List Highlights: Brookdale Senior Living, Best Buy, Chemed and E I Du Pont De Nemours

Zacks Sell List Highlights: Brookdale Senior Living, Best Buy, Chemed and E I
                              Du Pont De Nemours

PR Newswire

CHICAGO, Dec. 20, 2012

CHICAGO, Dec. 20, 2012 /PRNewswire/ -- Zacks.com releases details on a group
of stocks that are currently members of the exclusive Zacks #5 Rank List –
Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5
(Strong Sell): Brookdale Senior Living, Inc. (NYSE:BKD)  and Best Buy Co.,
Inc. (NYSE:BBY). Further, Zacks announced #4 Rankings (Sell) on two other
widely held stocks: Chemed Corporation (NYSE:CHE) and E I Du Pont De Nemours
And Co (NYSE:DD).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

To see the full Zacks #5 Rank List - Stocks to Sell Now visit:
http://at.zacks.com/?id=92

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List
of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall
Street continued to tout stocks during the market declines of the last few
years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why BKD and BBY have a Zacks Rank of #5 (Strong Sell)
and should most likely be sold or avoided for the next one to three months.
Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the
Zacks Rank universe:

Brookdale Senior Living, Inc. (NYSE:BKD) announced third -quarter loss of 10
cents per share on November 8 which came behind the Zacks Consensus Estimate
by 7 cents. The diluted earnings per share also fell by 11.11% on a
year-over-year basis. The Zacks Consensus Estimate for the current year
slipped 16 cents per share to a loss of 41 cents in the last 60 days. Next
year's estimate also dipped 15 cents per share to 1 cent per share in that
time span.

Best Buy Co., Inc. (NYSE:BBY) posted a third -quarter profit of 3 cents per
share on November 20, which came in 9 cents wider than the average forecast.
The Zacks Consensus Estimate for 2012 fell to a profit of $2.48 per share from
$2.81 over the past month with 20 out of 20 covering analysts slashed
forecasts. Next year's forecasts slipped 44 cents to $2.24 per share in the
same time span.

Here is a synopsis of why CHE and DD have a Zacks Rank of 4 (Sell) and should
also most likely be sold or avoided for the next one to three months. Note
that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

Chemed Corporation (NYSE:CHE) third -quarter profit of $1.20 per share, posted
on October 29, lagged analysts projections by nearly 1.64%. For 2012, the
Zacks Consensus Estimate moved down 23 cents in the last 60 days as none out
of the 2 covering analysts cut back on forecasts. The forecast for next year
slid 11 cents to $4.46 per share in the same time span.

E I Du Pont De Nemours And Co (NYSE:DD) reported a third-quarter profit of 44
cents per share on October 23, that fell 4.35% short of the Zacks Consensus
Estimate. The full-year average forecast is currently pegged at $3.37 per
share, compared with the last 30 days projection of $3.98. Next year's
forecast dropped 38 cents per share in the same period.

Truly taking advantage of the Zacks Rank requires the understanding of how it
works. The free special report; "Zacks Rank Guide: Harnessing the Power of
Earnings Estimate Revisions" is available to provide this insightful
background. Download a free copy now to prosper in the years to come at
http://at.zacks.com/?id=93

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are
the most powerful force impacting stock prices." Since inception in 1988, #1
Rank Stocks have generated an average annual return of +28%. During the
2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500
tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong
Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since
1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (2.8%
versus +9.7%). Thus, the Zacks Rank system allows investors to truly manage
portfolio trading effectively.

Visit http://www.zacks.com/performance for information about the performance
numbers displayed in this press release.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of
Zacks Rank Buy stocks and highlights those stocks poised to outperform the
market. Subscribe to this free newsletter today by visiting
http://at.zacks.com/?id=94

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed
in 1978 by Len Zacks. As a PhD from MIT Len knew he could find patterns in
stock market data that would lead to superior investment results. Amongst his
many accomplishments was the formation of his proprietary stock picking
system; the Zacks Rank, which continues to outperform the market by nearly a 3
to 1 margin. The best way to unlock the profitable stock recommendations and
market insights of Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow of
Profitable ideas GUARANTEED to be worth your time! Register for your free
subscription to Profit from the Pros at http://at.zacks.com/?id=95

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities
(including a broker-dealer and an investment adviser), which may engage in
transactions involving the foregoing securities for the clients of such
affiliates.

Disclaimer: Past performance does not guarantee future results. Investors
should always research companies and securities before making any investments.
Nothing herein should be construed as an offer or solicitation to buy or sell
any security.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com

SOURCE Zacks Investment Research, Inc.

Website: http://www.zacks.com